Parabellum buys anti-counterfeit specialist combatting rise in fake drugs


Parabellum Investments has acquired anti-counterfeit specialist Advanco, which helps to combat the rise in fake drugs, as pharmaceuticals giants rush to develop treatments for Covid-19.

Advanco provides tracking systems for serialised pharmaceutical products. Its serialisation software, sold under the ARC brand, allows manufacturers to track the serial numbers of medicines. Based in Brussels, Advanco provides its systems to global companies including Pfizer, Zentiva and Helsinn, across 35 countries. The company has revenues…

Read full article: